摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-甲氧基苯基)-4,5-二氢恶唑 | 74272-88-1

中文名称
2-(2-甲氧基苯基)-4,5-二氢恶唑
中文别名
——
英文名称
2-o-methoxyphenyl-2-oxazoline
英文别名
2-(o-Methoxyphenyl)oxazoline;o-methoxyphenyloxazoline;Oxazole, 4,5-dihydro-2-(2-methoxyphenyl)-;2-(2-methoxyphenyl)-4,5-dihydro-1,3-oxazole
2-(2-甲氧基苯基)-4,5-二氢恶唑化学式
CAS
74272-88-1
化学式
C10H11NO2
mdl
——
分子量
177.203
InChiKey
UABFDXDSFKGWJM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    30.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Oxazolinyl‐Assisted Ru(II)‐Catalyzed C−H Functionalization Based on Carbene Migratory Insertion: A One‐Pot Three‐Component Cascade Cyclization
    作者:Gangam Srikanth Kumar、Nandkishor Prakash Khot、Manmohan Kapur
    DOI:10.1002/adsc.201801362
    日期:2019.1.11
    A rare, ruthenium‐catalyzed, oxazolinlyl assisted C−H functionalization and threecomponent cascade cyclization for the synthesis of isoquinolinones via a metal‐carbene migratory insertion is reported. The transformation is unique since it involves the formation of multiple bonds in one pot via C−H functionalization and ring opening of oxazolines. Detailed mechanistic investigations reveal interesting
    据报道,一种稀有的钌催化的恶唑啉基辅助的CH功能化和三组分级联环化反应通过金属卡宾迁移插入合成异喹啉酮。这种转变是独特的,因为它涉及通过CH功能化和恶唑啉的开环在一个罐中形成多个键。详细的机械研究揭示了有关转化模式的有趣见解,涉及可逆的CH活化,重氮化合物的迁移插入和级联环化,这是转化的关键步骤。
  • Ag <sup>I</sup> ‐Catalyzed Reaction of Enol Diazoacetates and Imino Ethers: Synthesis of Highly Functionalized Pyrroles
    作者:Kuiyong Dong、Ahmad Humeidi、Wendell Griffith、Hadi Arman、Xinfang Xu、Michael P. Doyle
    DOI:10.1002/anie.202101641
    日期:2021.6.7
    AgI-catalyzed efficient method for the coupling of imino ethers and enol diazoacetates through a [3+2]-cycloaddition/C−O bond cleavage/[1,5]-proton transfer cascade process is reported. The general class of imino ethers that includes oxazolines, benzoxazoles and benzimidates are applicable substrates for these reactions that provide direct access to fully substituted pyrroles with uniformly high chemo- and
    报道了一种前所未有的 Ag I催化有效方法,用于通过 [3+2]-环加成/C-O 键裂解/[1,5]-质子转移级联过程偶联亚氨基醚和烯醇重氮乙酸酯。包括恶唑啉、苯并恶唑和苯甲亚胺酯在内的一般亚氨基醚类是这些反应的适用底物,可直接获得具有均匀高化学和区域选择性的完全取代的吡咯。吡咯 2-、5- 和 N-位取代的高度可变性表征了这种方法,该方法也提供了通过对所得 N-官能吡咯的轻松修饰来进一步实现吡咯多样化的切入点。
  • 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders
    申请人:E. I. Du Pont de Nemours and Company
    公开号:US05236934A1
    公开(公告)日:1993-08-17
    Provided are 1,2,3,4-tetrahydroisoquinolines, methods for preparing them, pharmaceutical compositions containing them, and methods of using them to treat disorders of mammals mediated by AT.sub.2 receptors in the central nervous system.
    提供了1,2,3,4-四氢异喹啉,制备它们的方法,含有它们的药物组合物,以及使用它们治疗哺乳动物中枢神经系统AT.sub.2受体介导的疾病的方法。
  • [EN] 4-PYRIDINYL-N-ACYL-L-PHENYLALANINES<br/>[FR] 4-PYRIDINYL-N-ACYL-L-PHENYLALANINES
    申请人:HOFFMANN LA ROCHE
    公开号:WO2001042215A1
    公开(公告)日:2001-06-14
    Compounds of Formula (I) are disclosed wherein R1-R7 are as defined in the application and which have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4 and, therefore, are useful for treating diseases whose symptoms and or damage are related to the binding of VCAM-1 to cells expressing VLA-4, such as chronic inflammatory diseases.
    本文披露了化学式(I)的化合物,其中R1-R7如申请书中定义的那样,并且具有抑制VCAM-1与表达VLA-4的细胞之间结合的活性,因此可用于治疗症状和/或损伤与VCAM-1与表达VLA-4的细胞之间结合有关的疾病,例如慢性炎症性疾病。
  • Diephenyl carbocyclic thioamide derivatives
    申请人:——
    公开号:US20010041799A1
    公开(公告)日:2001-11-15
    It has been discovered that compounds of the formula: 1 and the pharmaceutically acceptable salts and esters thereof wherein X and Y are as defined below, inhibit the binding of VCAM-1 to VLA-4 and are useful in treating inflammation associated with chronic inflammatory diseases such as rheumatoid arthritis (RA), multiple sclerosis, (MS), asthma, and inflammatory bowel disease (I BD).
    已发现以下化合物的公式:1及其药学上可接受的盐和酯,其中X和Y的定义如下,能够抑制VCAM-1与VLA-4的结合,并且适用于治疗与慢性炎症性疾病相关的炎症,例如类风湿性关节炎(RA),多发性硬化症(MS),哮喘和炎症性肠病(I BD)。
查看更多